Biacore System: Unlocking Biomolecular Interaction Analysis with SPR Technology | ANT BIO PTE. LTD.
Surface Plasmon Resonance (SPR) technology, exemplified by the Biacore system, has revolutionized the study of biomolecular interactions, enabling real-time, label-free, and quantitative analysis of binding events between biological molecules. As a gold-standard tool for molecular interaction research, the Biacore system eliminates the limitations of traditional biochemical assays, providing precise insights into binding affinity, kinetic constants, and molecular specificity—critical data for life science research, drug discovery, and diagnostic development. ANT BIO PTE. LTD., a leading provider of high-quality life science reagents, offers a comprehensive portfolio of products optimized for use with the Biacore system, including recombinant proteins, high-specificity antibodies, and assay reagents that enhance the accuracy and reproducibility of SPR-based experiments.
1. Concept: Biacore System and Surface Plasmon Resonance (SPR) Technology
The Biacore system is a state-of-the-art analytical platform that leverages the optical phenomenon of Surface Plasmon Resonance (SPR) to study biomolecular interactions in real time, without the need for fluorescent or radioactive labeling. SPR occurs when a p-polarized light beam strikes a thin metal film (typically 50 nm gold) coated on a prism at a specific angle, generating surface plasmon waves at the metal-liquid interface. When biomolecules in a sample bind to ligands immobilized on the metal film, the refractive index at the interface changes, causing a measurable shift in the SPR angle.
This angle shift is directly proportional to the mass of molecules bound to the sensor chip surface, allowing the Biacore system to quantify association (kₐ) and dissociation (k_d) kinetic constants, calculate equilibrium dissociation constants (K_D), and assess binding specificity—all in real time. Unlike traditional assays that only provide endpoint data, the Biacore system captures the full dynamic profile of biomolecular binding and dissociation, offering a holistic understanding of molecular interactions that is indispensable for modern life science research.
2. Research Frontiers: Biacore System in Modern Biomolecular Research
The Biacore system has evolved from a specialized tool for protein-protein interaction studies to a versatile platform applied across cutting-edge research fields, driven by advancements in sensor chip design, high-throughput screening capabilities, and integration with other analytical technologies. Key research frontiers leveraging the Biacore system include:
High-throughput drug discovery: Ultra-high-throughput SPR screening for small molecule, antibody, and peptide binders to therapeutic targets, accelerating lead compound identification and optimization.
Structural biology and interaction dynamics: Combined use of Biacore with cryo-EM and X-ray crystallography to link molecular structure with binding kinetics, revealing the mechanistic basis of biomolecular interactions.
Single-molecule SPR analysis: Next-generation Biacore platforms enabling single-molecule interaction studies, providing insights into rare binding events and heterogeneous molecular populations.
SPR-MS integration: Coupling SPR with mass spectrometry (MS) for label-free identification of unknown binders from complex biological samples (e.g., cell lysates, serum), a powerful tool for biomarker discovery.
Point-of-care diagnostic development: Miniaturized SPR-based Biacore platforms for rapid, sensitive detection of disease biomarkers, pathogens, and therapeutic drugs in clinical samples.
Immunology and vaccine development: Quantification of antibody-antigen binding kinetics and affinity maturation, guiding the design of high-potency vaccines and neutralizing antibodies for infectious diseases and cancer.
3. Research Significance: Why the Biacore System is Indispensable for Life Science Research
Traditional biomolecular interaction assays—such as Western Blot (WB), ELISA, co-immunoprecipitation (Co-IP), and yeast two-hybrid—suffer from inherent limitations: they rely on labeling, provide only endpoint data, cannot quantify kinetic constants, and are prone to false positives from non-specific binding. The Biacore system addresses these limitations, offering transformative value for life science research, drug development, and diagnostics with far-reaching significance:
Label-free, real-time analysis: Eliminates the need for fluorescent/radioactive labels, which can alter molecular structure and binding behavior, and captures dynamic binding data from the moment molecules interact to dissociation.
Precise kinetic and affinity quantification: Provides accurate measurements of kₐ, k_d, and K_D—critical parameters for characterizing the strength and stability of biomolecular interactions, which cannot be obtained with traditional assays.
High sensitivity and low sample consumption: Detects binding events with picomolar to micromolar affinity and requires only small sample volumes (μL range), making it ideal for rare or low-abundance biomolecules.
Versatility across molecular interactions: Analyzes all major classes of biomolecular binding events, including protein-protein, protein-peptide, protein-DNA/RNA, protein-small molecule, antibody-antigen, and virus-receptor interactions.
Streamlines research and development: Accelerates target validation, lead compound screening, and diagnostic antibody development by providing rapid, reliable data that reduces experimental bias and redundant testing.
Enables mechanistic insights: Links binding kinetics to biological function, revealing how molecular interactions drive physiological and pathological processes—an essential step for understanding disease mechanisms and designing targeted therapeutics.
For academic researchers, biotech startups, and pharmaceutical enterprises, the Biacore system is not just an analytical tool—it is a cornerstone of modern biomolecular research that unlocks new insights into the molecular basis of life and drives the development of novel therapeutics and diagnostics.
4. Core Applications and Research Methods of the Biacore System
The Biacore system’s versatility and precision make it applicable across virtually all areas of life science research, with four core application areas that highlight its unique value in advancing scientific discovery and biotechnological development. Each application leverages the system’s ability to provide real-time, quantitative kinetic and affinity data that transcends the limitations of traditional assays.
4.1 Kinetic Constant and Binding Affinity Determination
The most fundamental application of the Biacore system is the precise quantification of kinetic constants (kₐ, k_d) and equilibrium dissociation constants (K_D) for biomolecular interactions. This addresses a critical gap in traditional assays, which only measure binding presence/absence or relative affinity, not the dynamic binding behavior that defines biological function.
The Biacore system monitors mass changes on the sensor chip surface in real time, generating a sensorgram—a plot of response units (RU) vs. time—that visualizes the entire binding process: association (analyte binding to immobilized ligand), steady state (equilibrium between binding and dissociation), and dissociation (analyte release from the ligand). Advanced software fits this data to kinetic models, calculating kₐ, k_d, and K_D with high precision.
This application is invaluable for characterizing antibody-antigen binding, protein-protein interactions, and protein-small molecule binding, enabling researchers to rank binders by affinity and kinetic stability—an essential step for antibody discovery, drug screening, and target validation. Unlike ELISA (a concentration-dependent endpoint assay), the Biacore system provides concentration-independent kinetic data, making it the gold standard for quantifying biomolecular binding strength.
4.2 Deciphering Protein Structure-Function Relationships and Physiological Regulation
The Biacore system is a powerful tool for linking molecular structure to biological function, enabling researchers to investigate how mutations, post-translational modifications, or environmental factors alter biomolecular interactions and drive physiological or pathological processes. By measuring changes in binding kinetics/affinity caused by structural modifications, the Biacore system reveals the mechanistic basis of protein function and physiological regulation.
Notable research examples include:
A study by Hirano et al. that used the Biacore system to demonstrate that the G576V mutation in the rice protein SLR1 accelerates its dissociation from GID1, destabilizing the SLR1-GID1 complex and inhibiting gibberellin (GA) signaling—directly leading to a dwarf rice phenotype.
Research by Magulies et al. that employed the Biacore system to quantify binding affinities between MHC molecules, TCR, and peptide antigens, proposing a key biological model: T-cell activation requires simultaneous stimulation of multiple TCRs by abundant peptide-MHC complexes on antigen-presenting cells.
These studies illustrate how the Biacore system transforms structural data into functional insights, providing a mechanistic understanding of biological processes that is impossible to obtain with traditional assays.
4.3 Disease Biomarker Discovery and Diagnostic Development
Biomarkers are critical for early disease diagnosis, prognosis monitoring, and treatment efficacy assessment, but their development is hindered by the need for sensitive, specific, and quantitative detection methods. The Biacore system addresses this challenge, offering a label-free, highly sensitive platform for biomarker discovery and diagnostic assay development.
For biomarker discovery, the Biacore system (especially when integrated with MS) can identify unknown biomolecules that bind to disease-specific targets from complex biological samples, enabling the discovery of novel diagnostic and prognostic biomarkers. For diagnostic development, the system is used to establish calibration curves with purified biomarker standards, enabling precise, quantitative detection of biomarkers in clinical samples (e.g., serum, plasma, urine) with high sensitivity and stability.
Compared to conventional diagnostic methods (e.g., ELISA, molecular diagnostics), the Biacore system offers faster detection, lower sample consumption, and resistance to interference from complex sample matrices—making it ideal for developing next-generation point-of-care and clinical diagnostics for cancer, infectious diseases, and autoimmune disorders.
4.4 High-Affinity Diagnostic Antibody Screening and Validation
The development of high-quality diagnostic antibodies is a bottleneck for in vitro diagnostic (IVD) assay development, especially for novel or low-abundance biomarkers where traditional screening methods (e.g., ELISA) suffer from low sensitivity and poor specificity. The Biacore system provides a gold-standard platform for screening and validating high-affinity diagnostic antibodies, overcoming the limitations of conventional methods.
By immobilizing recombinant biomarker proteins on Biacore sensor chips and flowing antibody libraries over the chip surface, researchers can rapidly screen for antibodies with high binding affinity, slow dissociation kinetics, and high specificity—key properties for sensitive and specific diagnostic assays. The Biacore system also enables the characterization of antibody cross-reactivity, ensuring that diagnostic antibodies do not bind to off-target molecules in clinical samples.
This application streamlines the development of diagnostic antibodies for IVD assays (e.g., immunochromatography, chemiluminescence), reducing the time and cost of assay development and improving the performance of clinical diagnostics.
5. ANT BIO PTE. LTD.’s Reagents: Empowering Biacore System Experiments
ANT BIO PTE. LTD. offers a curated portfolio of high-quality life science reagents optimized for use with the Biacore system, designed to enhance the accuracy, reproducibility, and efficiency of SPR-based biomolecular interaction studies. Our reagents—spanning recombinant proteins, antibodies, and assay tools—are produced to the strictest quality standards, with verified purity, bioactivity, and batch-to-batch consistency, ensuring reliable results in Biacore experiments. As a one-stop provider of life science reagents, our three specialized sub-brands (Absin, Starter, UA) offer products tailored to every stage of a Biacore experiment, from ligand immobilization to analyte detection and data validation.
Key Product Advantages for Biacore Experiments
High Purity: Recombinant proteins and antibodies with >95% purity (verified by SDS-PAGE/HPLC) minimize non-specific binding to Biacore sensor chips, reducing background noise and improving data accuracy.
High Bioactivity: Rigorously validated bioactivity ensures that our reagents maintain their native structure and binding properties—critical for accurate kinetic and affinity quantification in SPR assays.
Low Endotoxin: Endotoxin levels <1.0 EU/μg for all recombinant proteins and antibodies eliminate interference from endotoxin-protein interactions, a common source of non-specific binding in Biacore experiments.
Ready-to-Use Formulation: Supplied as soluble, sterile-filtered reagents in buffer systems compatible with Biacore running buffers (e.g., PBS), eliminating the need for additional processing and reducing experimental variability.
6. Brand Mission of ANT BIO PTE. LTD.
ANT BIO PTE. LTD. is dedicated to empowering life science research and biotechnological innovation by providing high-quality, reliable, and application-optimized life science reagents. Our core mission is to be the trusted partner of researchers worldwide, offering a one-stop solution for their experimental needs through our three specialized sub-brands that cover the full spectrum of life science research:
Absin: Specializes in general life science reagents and assay kits, including Biacore-compatible running buffers, sensor chip regeneration solutions, and protein purification kits—essential for optimizing Biacore experiment setup and sample preparation.
Starter: Our flagship antibody brand, offering high-specificity, high-affinity monoclonal/polyclonal antibodies (including isotype controls) for use as ligands/analytes in Biacore experiments, as well as antibodies for validating SPR results with traditional assays (WB, IF, ELISA).
UA: The premier provider of recombinant proteins, including target antigens, therapeutic targets, and biomarker proteins—produced in prokaryotic/eukaryotic expression systems with native post-translational modifications, ideal for immobilization as ligands on Biacore sensor chips.
We combine cutting-edge manufacturing technology, strict quality control, and a customer-centric approach to deliver reagents that drive reproducible, impactful research. By developing products optimized for key analytical platforms like the Biacore system, we strive to bridge the gap between reagent supply and experimental innovation, enabling researchers to unlock new insights into biomolecular interactions and drive medical progress.
7. Related Product List from ANT BIO PTE. LTD. for Biacore System Experiments
ANT BIO PTE. LTD. offers a comprehensive portfolio of products tailored to every stage of Biacore-based biomolecular interaction analysis, from sample preparation and ligand immobilization to kinetic analysis and result validation. Our products are optimized for compatibility with all Biacore platform models and sensor chip types, ensuring seamless integration into your experimental workflow:
UA Brand (Recombinant Proteins – Ligands/Analytes for Biacore)
Recombinant target proteins (therapeutic targets, biomarkers, signaling proteins) with native post-translational modifications
Recombinant antibody fragments (Fab, scFv) for antibody-antigen interaction studies
Recombinant DNA/RNA-binding proteins and nucleic acid-binding domains
Recombinant viral proteins and receptors for virus-host interaction research
High-purity fusion proteins (with His/Flag/Fc tags) for easy immobilization on Biacore sensor chips
Starter Brand (Antibodies for Biacore Experiments & Validation)
High-affinity monoclonal/polyclonal antibodies for use as ligands/analytes in antibody-antigen binding studies
Isotype control antibodies (mouse, rat, rabbit) for assessing non-specific binding in Biacore assays
Anti-tag antibodies (His, Flag, Myc, Fc) for detecting tagged recombinant proteins in Biacore experiments
Validation antibodies for confirming SPR results with WB, IF, ELISA, and FACS
Absin Brand (Biacore Assay Reagents & General Life Science Tools)
Biacore-compatible running buffers (PBS, HBS-EP+) and sample dilution buffers
Sensor chip regeneration solutions (low/high pH, detergent-based) for repeated chip use
Protein purification kits (Protein A/G, Ni-NTA, antigen affinity) for purifying ligands/analytes for Biacore experiments
Endotoxin removal kits and testing reagents for reducing non-specific binding
Microcentrifuge tubes and syringeless filters for sterile sample preparation for Biacore analysis
Brand Promotion Copy
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
